Skip to main content

and
  1. No Access

    Article

    Modulation of the Immunological Milieu in Acute Aneurysmal Subarachnoid Hemorrhage: The Potential Role of Monocytes Through CXCL10 Secretion

    Emerging evidence indicates that aneurysmal subarachnoid hemorrhage (aSAH) elicits a response from both innate and adaptive immune systems. An upregulation of CD8 + CD161 + cells has been observed in the cere...

    Sebastian Sanchez, Michael S. Chimenti, Yongjun Lu in Translational Stroke Research (2024)

  2. Article

    Open Access

    Selective neuroimmune modulation by type I interferon drives neuropathology and neurologic dysfunction following traumatic brain injury

    Accumulating evidence suggests that type I interferon (IFN-I) signaling is a key contributor to immune cell-mediated neuropathology in neurodegenerative diseases. Recently, we demonstrated a robust upregulatio...

    Brittany P. Todd, Zili Luo, Noah Gilkes in Acta Neuropathologica Communications (2023)

  3. Article

    Open Access

    T cells, particularly activated CD4+ cells, maintain anti-CD20-mediated NK cell viability and antibody dependent cellular cytotoxicity

    Anti-CD20 monoclonal antibody (mAb) therapy is a mainstay of therapy for B cell malignancies, however many patients fail to respond or eventually develop resistance. The current understanding of mechanisms res...

    Zhaoming Wang, Michael S. Chimenti, Christopher Strouse in Cancer Immunology, Immunotherapy (2022)

  4. Article

    Open Access

    Traumatic brain injury results in unique microglial and astrocyte transcriptomes enriched for type I interferon response

    Traumatic brain injury (TBI) is a leading cause of death and disability that lacks neuroprotective therapies. Following a TBI, secondary injury response pathways are activated and contribute to ongoing neurode...

    Brittany P. Todd, Michael S. Chimenti, Zili Luo in Journal of Neuroinflammation (2021)

  5. No Access

    Protocol

    Biophysical Methods for Identifying Fragment-Based Inhibitors of Protein-Protein Interactions

    Fragment-based lead discovery complements high-throughput screening and computer-aided drug design for the discovery of small-molecule inhibitors of protein-protein interactions. Fragments are molecules with m...

    Samuel J. Pfaff, Michael S. Chimenti, Mark J. S. Kelly in Protein-Protein Interactions (2015)